These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 736221)

  • 1. Studies on the vincamine-papaverine association ii. acute toxicity in experimental animals as a function of the speed of infusion.
    Nunziata A; Costrini R; Mercatelli P; Perri GC
    Agressologie; 1978; 19(3):215-9. PubMed ID: 736221
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the vincamine-papaverine association. IV. Interference with beta-receptors in experimental animals.
    Cattani L; Costrini R; Manani G; Galzigna L; Giron GP; Costa G; Civran E; Bossi M
    Agressologie; 1978; 19(6):385-91. PubMed ID: 35999
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the vincamine-papaverine association. V. Interference with alpha receptors. Experimental study.
    Costrini R; Nunziata A; Galloro P; Cattani L
    Agressologie; 1979; 20(4):217-20. PubMed ID: 233543
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the vincamine-papaverine association. VI. Interference with alpha receptors. Preliminary clinical evidence.
    Pedini G; Costa G; Bossi M; Manani G
    Agressologie; 1979; 20(4):221-3. PubMed ID: 233544
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients].
    Petruzzi E; Bucalossi A
    Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the vincamine-papaverine association. i. biochemical investigations.
    Costrini R; Galzigna L; Bianchi M; Nunziata A; Cattani L
    Agressologie; 1978; 19(3):211-4. PubMed ID: 736220
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental studies on the effects of vincamine and its analogues on cerebrovascular circulation].
    Imamoto T; Nukada T; Tada K
    No To Shinkei; 1977 Mar; 29(3):341-7. PubMed ID: 558779
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of a vincamine-papaverine combination on platelet aggregation in geriatric patients with glucose and/or lipid metabolism disorders].
    Petruzzi E; Bucalossi A; Chiostri R
    Minerva Cardioangiol; 1985 Sep; 33(9):561-4. PubMed ID: 4088484
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the vincamine-papaverine association iii. clinical use in cardiac patients.
    Pirani R; Cattani L; Tomasi AM; Masoni A
    Agressologie; 1978; 19(3):221-5. PubMed ID: 736222
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of the clinical effect of vincamine versus papaverine given parenterally in the acute phase of stroke.
    Thiery E; Otte G; Vander Eecken H
    Arzneimittelforschung; 1979; 29(3):671-4. PubMed ID: 582751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of vincamine on the mesenteric circulation in the rat. Microcirculatory evaluation of the vasodilator activity of vincamine].
    Piacenza G; Pesce E
    Farmaco Prat; 1978 Jul; 33(7):326-32. PubMed ID: 744233
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with the combination of vincamine and papaverine in chronic brain syndrome].
    Cacciatori D
    Clin Ter; 1979 Jun; 89(5):473-82. PubMed ID: 535324
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo antispasmodic activity of Sulcotidil.
    Roba J; Reuse-Blom S; Lambelin G
    Arch Int Pharmacodyn Ther; 1976 May; 221(1):54-9. PubMed ID: 962430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular action of vincamine hydrochloride].
    Piacenza G; Pesce E; Marchini F
    Farmaco Prat; 1978 Jul; 33(7):306-18. PubMed ID: 744231
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulatory effect of several cerebral circulatory drugs in man, with special reference to aminophylline, papaverine, cyclandelate, vincamine, prostaglandin E1 and isoxsuprine.
    Miyazaki M
    Jpn Circ J; 1978 Apr; 42(4):433-40. PubMed ID: 702768
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypotensive effect and toxicity of octadin and papaverine following their combined administration].
    Akhmed EK
    Farmakol Toksikol; 1976; 39(6):687-90. PubMed ID: 1024835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction of vincamine on various effects of amphetamine at the central level].
    Sardi B; Pesce E; Piacenza G
    Farmaco Prat; 1978 Aug; 33(8):351-7. PubMed ID: 748060
    [No Abstract]   [Full Text] [Related]  

  • 18. Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
    Maincent P; Le Verge R; Sado P; Couvreur P; Devissaguet JP
    J Pharm Sci; 1986 Oct; 75(10):955-8. PubMed ID: 3795026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in mouse hepatocytes caused by vincamin. A thin-sectioning and freeze-fracture study.
    Rassat J; Robenek H; Themann H
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Mar; 318(4):349-57. PubMed ID: 7078667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biologic availability of vincamine from tablets with a hydrophilic matrix. II].
    Rolland A; Gibassier D; Chemtob C; Le Verge R
    J Pharm Belg; 1984; 39(3):136-44. PubMed ID: 6481608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.